Brian Leyland-Jones

Emory University

$1,737,814

Attributed

$1,737,814

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $899.1K · FY2009–11

$1M$750K$500K$250K$0

'09

'10

'11

Funding mix

By agency

NIH$1,737,814 · 8

By mechanism

P30$974,994 · 6

R21$762,820 · 2

Top collaborators

No co-investigators on record.

Most similar at Emory University

Same institution · by research overlap

Rafi Ahmed$104,632,759
Laura M Wagner$4,461,526
Fadlo Raja Khuri$2,954,298
Joyce C. Ho$1,314,468
Vicki Stover Hertzberg$2,647,797

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsClinical TrialsInstitutesProgramsBiomarkerInstitutionBaseLeadCancer PatientMeetingsProtocols DocumentationCancer Center Support GrantClinical ResearchResourcesTumorLaboratoriesPhase Iii Clinical TrialsResearch PersonnelMonitoring Clinical TrialsSamplingMemberMalignant Breast NeoplasmCharacteristicsUniversities